Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SAXAGLIPTIN MONOHYDRATE, with a corresponding US DMF Number 26977.
Remarkably, this DMF maintains an Active status since its submission on May 03, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 14, 2013, and payment made on May 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II